JP2000510921A - 軌道用の防音装置 - Google Patents
軌道用の防音装置Info
- Publication number
- JP2000510921A JP2000510921A JP09541256A JP54125697A JP2000510921A JP 2000510921 A JP2000510921 A JP 2000510921A JP 09541256 A JP09541256 A JP 09541256A JP 54125697 A JP54125697 A JP 54125697A JP 2000510921 A JP2000510921 A JP 2000510921A
- Authority
- JP
- Japan
- Prior art keywords
- sound absorbing
- absorbing plate
- sound
- plate
- divided
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000009413 insulation Methods 0.000 title 1
- 239000002245 particle Substances 0.000 claims abstract description 16
- 239000003562 lightweight material Substances 0.000 claims abstract description 9
- 239000007767 bonding agent Substances 0.000 claims abstract description 8
- 239000012779 reinforcing material Substances 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims description 12
- 230000000295 complement effect Effects 0.000 claims description 7
- 230000033001 locomotion Effects 0.000 claims description 6
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 claims description 6
- 239000006096 absorbing agent Substances 0.000 claims description 3
- 239000011248 coating agent Substances 0.000 claims description 3
- 238000000576 coating method Methods 0.000 claims description 3
- 230000002787 reinforcement Effects 0.000 claims description 3
- 238000005096 rolling process Methods 0.000 claims description 3
- 230000001174 ascending effect Effects 0.000 claims description 2
- 230000001788 irregular Effects 0.000 claims description 2
- 230000002457 bidirectional effect Effects 0.000 claims 1
- 239000004065 semiconductor Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 230000008569 process Effects 0.000 description 6
- 239000000835 fiber Substances 0.000 description 5
- 229910000831 Steel Inorganic materials 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 239000010959 steel Substances 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000011358 absorbing material Substances 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 239000004568 cement Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 230000030279 gene silencing Effects 0.000 description 2
- 239000011491 glass wool Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002557 mineral fiber Substances 0.000 description 2
- 239000011490 mineral wool Substances 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 229920002522 Wood fibre Polymers 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 239000003351 stiffener Substances 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000002025 wood fiber Substances 0.000 description 1
Classifications
-
- E—FIXED CONSTRUCTIONS
- E01—CONSTRUCTION OF ROADS, RAILWAYS, OR BRIDGES
- E01B—PERMANENT WAY; PERMANENT-WAY TOOLS; MACHINES FOR MAKING RAILWAYS OF ALL KINDS
- E01B19/00—Protection of permanent way against development of dust or against the effect of wind, sun, frost, or corrosion; Means to reduce development of noise
- E01B19/003—Means for reducing the development or propagation of noise
Landscapes
- Architecture (AREA)
- Civil Engineering (AREA)
- Structural Engineering (AREA)
- Engineering & Computer Science (AREA)
- Building Environments (AREA)
- Soundproofing, Sound Blocking, And Sound Damping (AREA)
- Railway Tracks (AREA)
- Power-Operated Mechanisms For Wings (AREA)
- Devices Affording Protection Of Roads Or Walls For Sound Insulation (AREA)
- Signal Processing Not Specific To The Method Of Recording And Reproducing (AREA)
- Fittings On The Vehicle Exterior For Carrying Loads, And Devices For Holding Or Mounting Articles (AREA)
- Magnetic Heads (AREA)
- Noise Elimination (AREA)
- Holo Graphy (AREA)
- Bridges Or Land Bridges (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.軌道のレールに取付けられ弾性側部を介して前記レールに支持される吸音板 を備えた、軌道用の防音装置であって、前記レール間に配置される前記吸音板が 前記レール間の空間に自立形式で架橋されている防音装置において、前記吸音板 (3、18、21)が、接合剤によって結合される多孔性軽量材料からなる粒子(9 )で構成されていること、前記吸音板(3、18、21)が、埋め込まれた補強材(1 1)を備えているとともに覆われない状態で配設されていることを特徴とする防 音装置。 2.前記吸音板(3、18、21)の上面(12)に加工が施されている請求項1に記 載の防音装置。 3.前記加工が不規則である請求項2に記載の防音装置。 4.前記吸音板(3、18、21)の前記上面が前記レール(2)に平行に延びるリ ブ(13)を備えている請求項2または請求項3に記載の防音装置。 5.前記リブ(13)が台形状の断面を有している請求項4に記載の防音装置。 6.前記吸音板(3)に、前記吸音板(3、18、21)の上面(12)へ向けられた管 状の吸音用開口(15)を有する空洞共鳴器(14)が形成されている請求項1から 請求項5のいずれか1項に記載の防音装置。 7.前記空洞共鳴器(14)の内壁および吸音用開口(15)が消音加工を施されて いる請求項6に記載の防音装置。 8.前記空洞共鳴器(14)の内壁および管状の吸音用開口(15)が消音層を備え ている請求項6に記載の防音装置。 9.前記空洞共鳴器(14)を構成する空洞が、下方に向かって拡開する状態で開 口するように形成されているとともに下面板(16)で覆われている請求項6から 請求項8のいずれか1項に記載の防音装置。 10.前記空洞共鳴器(14)を構成する前記空洞が、下方に向かって拡開する状態 で開口するように形成されているとともに、道床(17)と該当する吸音板(3) の下面との間にある空間と共に共鳴空洞を形成している請求項6から請求項8の いずれか1項に記載の防音装置。 11.前記空洞共鳴器(14)の消音された共鳴周波数が周波数領域150〜1000Hz内 、好ましくは500〜1000Hzの間にある請求項6から請求項10のいずれか1項に 記載の防音装置。 12.軌道(1)の両レール(2)間にある空間(22)に、各々が少なくとも1つ の担持リブ(4)によって前記レール(2)の継目板台座(23)に係合する2つ 一組で配設された分割吸音板(3a、3b)が架橋されており、各吸音板対の前記分 割吸音板(3a、3b)は、該分割吸音板の互いに向き合う縁部(26、27)で重なり 合って支持されているとともに、この場合、各分割吸音板には他方の分割吸音板 に向けられた縁部に沿って湾曲し交互に連続する担持部(28)および支持部(29 )が備えられており、前記担持部には吸音板上面(12)から始まり前記他方の分 割吸音板に向けられた縁部に至る下がり傾斜部(30)が形成されているとともに 、前記支持部(29)の下側には前記担持部の前記下がり傾斜部に相補的な形状を 有し吸音板下面(31)から始まり上方へ向かう下がり傾斜部(32)が形成され、 そしてまた、一方の分割吸音板の前記支持部は前記他方の分割吸音板の前記担持 部上に置かれるとともに前記他方の分割吸音板の前記支持部は前記一方の分割吸 音板の前記担持部上に置かれている請求項1から請求項11のいずれか1項に記 載の防音装置。 13.吸音板対の前記分割吸音板(3a、3b)が互いに接している面(33、34)に、 突出部(37)と、該突出部に対して相補的に形成され前記突出部が噛み合うよう になっている凹部(38)とが、前記分割吸音板(3a、3b)の相互の位置決めを行 うために備えられている、請求項12に記載の防音装置。 14.前記担持部(28)に備えられた担持面(33)が、前記吸音板対の前記他方の 分割吸音板に向けられた前記縁部から始まり前記吸音板下面(31)から離反して 先ず急な上り傾斜となった後に平坦となるように形成されている請求項12また は請求項13に記載の防音装置。 15.前記担持部(28)に備えられた担持面(33)が、各吸音板対の前記分割吸音 板(3a、3b)の平坦な状態でこの分割吸音板(3a、3b)が吸音板平面の方向(36 )に双方向運動することを阻害するような湾曲した形状を有する請求の範囲第14 項記載の防音装置。 16.下方に向けられた突出部(37)を前記支持部(29)の前縁(39)に備えるよ うにするとともに、この突出部(37)に対して相補的な凹部(38)を前記担持部 (28)の前記担持面(33)に備える請求項13から請求項15のいずれか1項に 記載の防音装置。 17.湾曲状態に形成された担持面(33)が、各々の吸音板対における分割吸音板 (3a、3b)が平坦な状態となるまで互いに向き合う前記担持面および支持面のス ライド運動または転がり運動が連続して可能であるような噛み合わせであって前 記平坦な状態ではこれらの分割吸音板は互いに動くことが阻止されるような噛み 合わせに応じて形成されている請求項15に記載の防音装置。 18.前記分割吸音板(3a、3b)が、互いに向き合う縁部(26、27)について前記 吸音板下面(31)から始まり上に向かって丸くなるように形成され、この曲率半 径は、前記分割吸音板(3a、3b)のこれらの縁部(26、27)とレール側の縁部( 42)との間における距離(41)と同じ大きさを有しているかまたはこれよりも小 さい請求項12から請求項17のいずれか1項に記載の防音装置。 19.吸音板対の前記分割吸音板(3a、3b)双方が吸音板下面(31)で1つの直線 (40)に沿って接近する状態で並んでいる請求項12から請求項18のいずれか 1項に記載の防音装置。 20.吸音板対の前記分割吸音板(3a、3b)双方が、前記吸音板下面(31)で湾曲 し噛み合う状態で並んでいる請求項12から請求項18のいずれか1項に記載の 防音装置。 21.前記分割吸音板(3a、3b)に備えられた補強材(11)が前記吸音板表面(36 )にわたって延びるとともに、前記担持部(28)にも、前記支持部(29)にも、 および前記担持リブ(4)にも掛かっている請求項12から請求項20のいずれ か1項に記載の防音装置。 22.前記担持部に備えられた担持面(33)と、前記支持部に備えられた支持面(34) との間に、弾性および/または衝突緩衝作用を有するライナーまたはコーティン グを備える請求項12から請求項21のいずれか1項に記載の防音装置。 23.前記吸音板(3、18、21)が、結合手段によって結合される多孔性軽量材料 からなる粒体(9)から構成されていること、そして、前記吸音板(3、18、21 ) が、埋め込まれた補強材(11)を備えていること、そしてまた、前記吸音板(3 、18、21)には、前記軌道に前記吸音板を組込む際に上面を形成するために備え られた前記吸音板(3、18、21)の大表面に向けられた管状の吸音開口(15)を 有する空洞共鳴器(14)が形成されている請求項1から請求項22のいずれか1 項に記載の防音装置用の吸音板。 24.前記空洞共鳴器(14)を構成する空洞が、前記管状の吸音用開口(15)の側 とは反対の吸音板側にある大表面に向かって拡開する状態で開口するように形成 された請求項23に記載の吸音板。 25.前記空洞共鳴器(14)を構成する空洞が、前記管状の吸音用開口(15)の側 とは反対の吸音板側で、下面板(16)によって覆われている請求項24に記載の 吸音板。 26.前記吸音板(3a、3b)が、接合剤によって結合される多孔性軽量材料からな る粒子から構成されていること、そして、前記吸音板(3a、3b)が、埋め込まれ た補強材を備えていること、そしてまた、前記吸音板(3a、3b)は、レールの継 目板台座に係合する担持リブ(4)を備えているとともに、該担持リブ(4)に 相対する縁側に、湾曲して続く状態で担持部(28)と支持部(29)とを備えてお り、前記担持部には前記吸音板上面(12)から始まり縁部に至る下がり傾斜部(30) が形成されているとともに、前記支持部(29)の下側には前記担持部の前記下が り傾斜部に相補的な形状を有し前記吸音板下面(31)から始まり上方へ向う下が り傾斜部(32)が形成されている請求項12から請求項22のいずれか1項に記 載の防音装置用の吸音板。 27.前記吸音板(3a、3b)には、前記軌道に前記吸音板を組込む際に上面を形成 するために備えられた前記吸音板(3a、3b)の大表面に向けられた管状の吸音用 開口(15)を有する空洞共鳴器(14)が形成されている請求項26に記載の吸音 板。 28.前記吸音板(3a、3b)に備えられた補強材(11)が吸音板表面全体にわたっ て延びるとともに、前記担持部(28)にも、前記支持部(29)にも、および前記 担持リブ(4)にも掛かっている請求項26または請求項27に記載の吸音板。
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT93496A AT403809B (de) | 1996-05-29 | 1996-05-29 | Schallschutzeinrichtung für gleise |
| AT934/96 | 1996-05-29 | ||
| AT0101596A AT405426B (de) | 1996-06-11 | 1996-06-11 | Schienengleiche eindeckung für gleise |
| AT1015/96 | 1996-06-11 | ||
| PCT/AT1997/000109 WO1997045592A1 (de) | 1996-05-29 | 1997-05-23 | Schallschutzeinrichtung für gleise |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2000510921A true JP2000510921A (ja) | 2000-08-22 |
| JP2000510921A5 JP2000510921A5 (ja) | 2005-01-13 |
| JP3822641B2 JP3822641B2 (ja) | 2006-09-20 |
Family
ID=25594370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP54125697A Expired - Fee Related JP3822641B2 (ja) | 1996-05-29 | 1997-05-23 | 軌道用の防音装置 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6253872B1 (ja) |
| EP (1) | EP0901536B1 (ja) |
| JP (1) | JP3822641B2 (ja) |
| CN (1) | CN100424268C (ja) |
| AT (1) | ATE229595T1 (ja) |
| AU (1) | AU738889B2 (ja) |
| CA (1) | CA2255946C (ja) |
| DE (1) | DE59708955D1 (ja) |
| DK (1) | DK0901536T3 (ja) |
| ES (1) | ES2186891T3 (ja) |
| HU (1) | HU221872B1 (ja) |
| NO (1) | NO316078B1 (ja) |
| TW (1) | TW345603B (ja) |
| WO (1) | WO1997045592A1 (ja) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007526412A (ja) * | 2004-03-05 | 2007-09-13 | グミュンドネル ファーチクタイル ゲゼルシャフト ミット ベシュレンクテル ハフトング ウント ツェーオー. カーゲー. | 騒音低減線路カバー |
| JP2008121395A (ja) * | 2006-11-14 | 2008-05-29 | Endeavor House Ltd | 伸縮性に優れた線路用吸音材 |
| JP2013508584A (ja) * | 2009-10-22 | 2013-03-07 | ユニフェルシテイト トウェンテ | 音回折器を有する道路 |
Families Citing this family (308)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19812481C2 (de) * | 1998-03-21 | 2002-08-22 | Johann Rath | Vorrichtung zur Dämpfung von Schallemissionen an Gleisanlagen |
| DE29905550U1 (de) * | 1999-03-26 | 2000-08-24 | DVG Deutsche Verpackungsmittel GmbH, 90552 Röthenbach | Absorptionsbelag zur Reduzierung der Schallabstrahlung für Gleiskörper |
| US7897140B2 (en) | 1999-12-23 | 2011-03-01 | Health Research, Inc. | Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents |
| US6481637B1 (en) * | 2000-11-20 | 2002-11-19 | Mcqueen Philip Jeffrey | Rail pad and method for strain attentuation |
| DE10111919A1 (de) * | 2001-03-13 | 2002-09-19 | Boegl Max Bauunternehmung Gmbh | Fahrwegträger |
| HU224236B1 (hu) * | 2001-12-14 | 2005-06-28 | Attila Szebeni | Vasúti acélhidaknál alkalmazható, egymáshoz csatlakoztatott elemekbõl álló, zaj- és rezgéscsökkentett mûanyag járólemezrendszer |
| US8829198B2 (en) | 2007-10-31 | 2014-09-09 | Proteotech Inc | Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies |
| EP1517684B1 (en) | 2002-06-27 | 2009-07-22 | Health Research, Inc. | Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy |
| WO2004005289A2 (en) | 2002-07-02 | 2004-01-15 | Health Research, Inc. | Efficient synthesis of pyropheophorbide a and its derivatives |
| AT6414U1 (de) * | 2002-07-17 | 2003-10-27 | Gmundner Fertigteile Gmbh | Gleisabdeckung |
| GB2399123B (en) * | 2003-03-05 | 2006-03-01 | Corus Uk Ltd | Rail damper |
| US20040248877A1 (en) * | 2003-04-30 | 2004-12-09 | Sandeep Gupta | Polycyclic diazodioxide-based Bcl-2 protein antagonists and use thereof |
| WO2004099158A1 (en) * | 2003-04-30 | 2004-11-18 | Ricerca Biosciences, Llc. | Monocyclic diazodioxide based bcl-2 protein antagonists |
| JP4847868B2 (ja) * | 2003-05-14 | 2011-12-28 | ニューロジェネティック ファーマシューティカルズ、 インコーポレイテッド | 化合物、及び、アミロイドベータの調節におけるその使用 |
| US20100331380A1 (en) * | 2009-06-29 | 2010-12-30 | Esposito Luke A | Compounds, Compositions, and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies |
| US8916598B2 (en) | 2003-05-30 | 2014-12-23 | Proteotech Inc | Compounds, compositions, and methods for the treatment of β-amyloid diseases and synucleinopathies |
| WO2005090370A1 (en) * | 2004-02-05 | 2005-09-29 | The Regents Of The University Of California | Pharmacologically active agents containing esterified phosphonates and methods for use thereof |
| US20100126797A1 (en) * | 2004-02-12 | 2010-05-27 | Humphries Eric C | Panel Assembly For Traffic Noise Barrier Wall |
| US7546900B2 (en) * | 2004-02-12 | 2009-06-16 | Evonik Cyro Llc | Panel assembly for traffic noise barrier wall |
| US8616331B2 (en) | 2004-02-12 | 2013-12-31 | Eric C. Humphries | Panel assembly for traffic noise barrier wall |
| KR20070032700A (ko) | 2004-05-20 | 2007-03-22 | 폴드알엑스 파마슈티칼스, 인크. | 트랜스티레틴을 안정화하고 트랜스티레틴 미스폴딩을억제하기 위한, 2-((헤테로)아릴)-벤즈옥사졸 화합물 및유도체, 그리고 조성물 및 방법 |
| EP1802303B1 (en) | 2004-09-17 | 2011-11-02 | Whitehead Institute For Biomedical Research | Compounds, compositions and methods of inhibiting a-synuclein toxicity |
| US20060067889A1 (en) * | 2004-09-27 | 2006-03-30 | Light Sciences Corporation | Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted PDT agents |
| US20070131480A1 (en) * | 2004-12-06 | 2007-06-14 | Corbin Maxwell H Jr | Sound arresting barrier |
| US7464791B2 (en) * | 2005-01-27 | 2008-12-16 | Pretty Products, Llc | Acoustic mats and methods for making the same |
| US20060230699A1 (en) * | 2005-03-22 | 2006-10-19 | Keene James R | Sound control flooring systems and methods therefor |
| US20090156545A1 (en) * | 2005-04-01 | 2009-06-18 | Hostetler Karl Y | Substituted Phosphate Esters of Nucleoside Phosphonates |
| EP1866319B1 (en) | 2005-04-01 | 2011-11-23 | The Regents of The University of California | Phosphono-pent-2-en-1-yl nucleosides and analogs |
| US8492428B2 (en) * | 2005-09-20 | 2013-07-23 | Mayo Foundation For Medical Education And Research | Small-molecule botulinum toxin inhibitors |
| WO2007076160A2 (en) * | 2005-12-28 | 2007-07-05 | Acidophil Llc | C-10 carbamates of taxanes |
| AU2007225088B2 (en) * | 2006-03-13 | 2012-09-13 | Kyorin Pharmaceutical Co., Ltd | Aminoquinolones as GSK-3 inhibitors |
| CA2647543A1 (en) * | 2006-03-29 | 2007-11-08 | Foldrx Pharmaceuticals, Inc. | Inhibition of alpha-synuclein toxicity |
| AU2007260579B2 (en) * | 2006-06-13 | 2012-09-06 | Newstyle Nominees Pty Ltd | Rail track crossing |
| ES2439994T3 (es) | 2006-08-28 | 2014-01-27 | Kyowa Hakko Kirin Co., Ltd. | Anticuerpos antagonistas monoclonales humanos específicos de LIGHT humano |
| PL2066662T3 (pl) | 2006-09-21 | 2013-05-31 | Kyorin Seiyaku Kk | Inhibitory hydrolaz serynowych |
| JP2010507585A (ja) | 2006-10-19 | 2010-03-11 | オースペックス・ファーマシューティカルズ・インコーポレイテッド | 置換インドール |
| US20080146605A1 (en) | 2006-12-19 | 2008-06-19 | Auspex Pharmaceuticals, Inc. | Preparation and utility of ccr5 inhibitors |
| CA2671766A1 (en) * | 2006-12-22 | 2008-07-03 | Encysive Pharmaceuticals, Inc. | Modulators of c3a receptor and methods of use thereof |
| PT2144604E (pt) | 2007-02-28 | 2011-10-19 | Conatus Pharmaceuticals Inc | Métodos para o tratamento da hepatite c viral crónica utilizando ro-113-0830 |
| WO2008106167A1 (en) * | 2007-02-28 | 2008-09-04 | Conatus Pharmaceuticals, Inc. | Combination therapy comprising matrix metalloproteinase inhibitors and caspase inhibitors for the treatment of liver diseases |
| WO2008140859A1 (en) | 2007-03-15 | 2008-11-20 | Auspex Pharmaceuticals, Inc. | Deuterated venlafaxines and 0-desmetylvenlafaxines with serotoninergic and / or norepinephrinergic activity |
| US7892776B2 (en) | 2007-05-04 | 2011-02-22 | The Regents Of The University Of California | Screening assay to identify modulators of protein kinase A |
| EP2170062A4 (en) * | 2007-07-12 | 2010-12-29 | Tragara Pharmaceuticals Inc | METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER DISORDERS, TUMORS AND TUMOR-DISORDED DISEASES |
| WO2009035634A2 (en) * | 2007-09-11 | 2009-03-19 | Activx Biosciences, Inc. | Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors |
| CN102344457B (zh) | 2007-09-12 | 2015-07-22 | 杏林制药株式会社 | 作为 gsk-3 抑制剂的螺环状氨基喹诺酮 |
| US20090264421A1 (en) * | 2007-10-05 | 2009-10-22 | Bible Keith C | Methods and Compositions for Treating Cancer |
| WO2009059512A1 (en) * | 2007-11-07 | 2009-05-14 | Wai Lun Ho | Tunable vibration absorbing device |
| JP2011504485A (ja) * | 2007-11-21 | 2011-02-10 | ファーマクシス リミテッド | Ssao/vap−1のハロアリルアミン阻害剤およびその用途 |
| WO2009111611A2 (en) * | 2008-03-05 | 2009-09-11 | Proteotech Inc. | Compounds, compositions and methods for the treatment of islet amyloid polypeptide (iapp) accumulation in diabetes |
| SI2947072T1 (sl) | 2008-03-17 | 2017-03-31 | Ambit Biosciences Corporation | 1-(3-(6,7-dimetoksikinazolin-4-iloksi)fenil)-3-(5-1,1,1-trifluoro-2- metilpropan-2-il)izoksazol-3-il)urea kot modulator raf kinaze pri zdravljenju rakavih bolezni |
| US20120034155A1 (en) * | 2010-08-03 | 2012-02-09 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Artificial cells |
| CN101658533A (zh) * | 2008-08-29 | 2010-03-03 | 首都医科大学宣武医院 | 抗肿瘤药物的干细胞递送 |
| US8048204B2 (en) | 2008-09-23 | 2011-11-01 | Rwdi Air Inc. | Wall assembly |
| WO2010088450A2 (en) | 2009-01-30 | 2010-08-05 | Celladon Corporation | Methods for treating diseases associated with the modulation of serca |
| US8568793B2 (en) | 2009-02-11 | 2013-10-29 | Hope Medical Enterprises, Inc. | Sodium nitrite-containing pharmaceutical compositions |
| AR075633A1 (es) | 2009-02-27 | 2011-04-20 | Ambit Biosciences Corp | Compuestos moduladores de jak quinasa y sus metodos de uso |
| EP2403860B1 (en) | 2009-03-04 | 2015-11-04 | IDENIX Pharmaceuticals, Inc. | Phosphothiophene and phosphothiazole as hcv polymerase inhibitors |
| MX2011009413A (es) | 2009-03-11 | 2011-10-21 | Ambit Biosciences Corp | Combinacion de una indazolilaminopirrolotriazina y taxano para tratamiento contra cancer. |
| BRPI1008974A2 (pt) * | 2009-03-11 | 2017-06-06 | Kyorin Seiyaku Kk | composto, composição farmacêutica, e, método para tratar, prevenir ou melhorar uma doença mediada com gsk-3 |
| US8146310B2 (en) * | 2009-03-11 | 2012-04-03 | Keene Building Products Co., Inc. | Noise control flooring system |
| WO2010110686A1 (en) | 2009-03-27 | 2010-09-30 | Pathway Therapeutics Limited | Pyrimidinyl and 1,3,5 triazinyl benzimidazoles and their use in cancer therapy |
| SG174527A1 (en) | 2009-03-27 | 2011-11-28 | Pathway Therapeutics Inc | Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy |
| RU2539591C2 (ru) | 2009-04-22 | 2015-01-20 | Аксикин Фармасьютикалз, Инк. | Антагонисты арилсульфонамида ccr3 |
| KR101687144B1 (ko) | 2009-04-22 | 2016-12-15 | 액시킨 파마수티컬스 인코포레이티드 | 2,5-이치환된 아릴설폰아마이드 ccr3 길항제 |
| EP2727908A3 (en) | 2009-04-22 | 2014-08-20 | Axikin Pharmaceuticals, Inc. | 2,5-disubstituted arylsulfonamide CCR3 antagonists |
| WO2011003870A2 (en) | 2009-07-06 | 2011-01-13 | Creabilis S.A. | Mini-pegylated corticosteroids, compositions including same, and methods of making and using same |
| US8486939B2 (en) | 2009-07-07 | 2013-07-16 | Pathway Therapeutics Inc. | Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy |
| AU2010270605B2 (en) | 2009-07-08 | 2014-07-31 | Hope Medical Enterprises, Inc. Dba Hope Pharmaceuticals | Sodium thiosulfate-containing pharmaceutical compositions |
| US8404728B2 (en) | 2009-07-30 | 2013-03-26 | Mayo Foundation For Medical Education And Research | Small-molecule botulinum toxin inhibitors |
| EP2461811B1 (en) | 2009-08-05 | 2016-04-20 | Idenix Pharmaceuticals LLC. | Macrocyclic serine protease inhibitors useful against viral infections, particularly hcv |
| JP2013502429A (ja) | 2009-08-19 | 2013-01-24 | アムビト ビオスシエンセス コルポラチオン | ビアリール化合物及びその使用方法 |
| TW201120037A (en) | 2009-10-26 | 2011-06-16 | Sunesis Pharmaceuticals Inc | Compounds and methods for treatment of cancer |
| WO2011056764A1 (en) | 2009-11-05 | 2011-05-12 | Ambit Biosciences Corp. | Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles |
| WO2011057214A2 (en) | 2009-11-09 | 2011-05-12 | Neurogenetic Pharmaceuticals, Inc. | Gamma-secretase modulatory compounds, methods for identifying same, and uses therefor |
| US8528286B2 (en) * | 2009-11-10 | 2013-09-10 | Keene Building Products Co., Inc. | Sound control mat |
| US20110301235A1 (en) | 2009-12-02 | 2011-12-08 | Alquest Therapeutics, Inc. | Organoselenium compounds and uses thereof |
| KR20120118008A (ko) | 2009-12-18 | 2012-10-25 | 아이데닉스 파마슈티칼스, 인코포레이티드 | 5,5-융합 아릴렌 또는 헤테로아릴렌 간염 c 바이러스 억제제 |
| IN2012DN04858A (ja) * | 2009-12-23 | 2015-09-25 | Map Pharmaceuticals Inc | |
| WO2011094890A1 (en) | 2010-02-02 | 2011-08-11 | Argusina Inc. | Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators |
| AU2011223873B2 (en) | 2010-03-02 | 2015-06-25 | Axikin Pharmaceuticals, Inc. | Isotopically enriched arylsulfonamide CCR3 antagonists |
| WO2011112689A2 (en) | 2010-03-11 | 2011-09-15 | Ambit Biosciences Corp. | Saltz of an indazolylpyrrolotriazine |
| EP2547655B1 (en) | 2010-03-17 | 2016-03-09 | Axikin Pharmaceuticals, Inc. | Arylsulfonamide ccr3 antagonists |
| WO2011150201A2 (en) | 2010-05-27 | 2011-12-01 | Ambit Biosciences Corporation | Azolyl amide compounds and methods of use thereof |
| WO2011150198A1 (en) | 2010-05-27 | 2011-12-01 | Ambit Biosciences Corporation | Azolyl urea compounds and methods of use thereof |
| JP6019015B2 (ja) | 2010-06-01 | 2016-11-02 | ビオトヘルイク, インコーポレイテッド | 6−シクロヘキシル−1−ヒドロキシ−4−メチル−2(1h)−ピリドンを使用する血液悪性疾患の治療方法 |
| MX2012013879A (es) | 2010-06-01 | 2013-04-03 | Biotheryx Inc | Derivados de hidroxipiridona, composiciones farmceuticas de los mismos y su uso terapeutico para tratar enfermedades proliferativas. |
| MX2012014273A (es) | 2010-06-07 | 2013-03-22 | Novomedix Llc | Compuestos furanilo y su uso. |
| US20130178522A1 (en) | 2010-07-19 | 2013-07-11 | James M. Jamison | Vitamin c and chromium-free vitamin k, and compositions thereof for treating an nfkb-mediated condition or disease |
| EP2611448A1 (en) | 2010-09-01 | 2013-07-10 | Ambit Biosciences Corporation | 7-cyclylquinazoline derivatives and methods of use thereof |
| WO2012030918A1 (en) | 2010-09-01 | 2012-03-08 | Ambit Biosciences Corporation | Adenosine a3 receptor modulating compounds and methods of use thereof |
| ES2579942T3 (es) | 2010-09-01 | 2016-08-17 | Ambit Biosciences Corporation | Pirazolilaminoquinazolina ópticamente activa y composiciones farmacéuticas y métodos de uso de la misma |
| EP2611793A1 (en) | 2010-09-01 | 2013-07-10 | Ambit Biosciences Corporation | 2-cycloquinazoline derivatives and methods of use thereof |
| WO2012030924A1 (en) | 2010-09-01 | 2012-03-08 | Ambit Biosciences Corporation | Azolopyridine and azolopyrimidine compounds and methods of use thereof |
| US20130296363A1 (en) | 2010-09-01 | 2013-11-07 | Ambit Biosciences Corporation | Quinoline and isoquinoline derivatives for use as jak modulators |
| WO2012030948A1 (en) | 2010-09-01 | 2012-03-08 | Ambit Biosciences Corporation | Quinazoline compounds and methods of use thereof |
| US20130317045A1 (en) | 2010-09-01 | 2013-11-28 | Ambit Biosciences Corporation | Thienopyridine and thienopyrimidine compounds and methods of use thereof |
| EP2611794A1 (en) | 2010-09-01 | 2013-07-10 | Ambit Biosciences Corporation | 4-azolylaminoquinazoline derivatives and methods of use thereof |
| CN103270030B (zh) | 2010-09-01 | 2016-01-20 | 埃姆比特生物科学公司 | 吡唑基氨基喹唑啉的氢溴酸盐 |
| WO2012044641A1 (en) | 2010-09-29 | 2012-04-05 | Pathway Therapeutics Inc. | 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy |
| CN103298786B (zh) | 2010-10-11 | 2016-01-20 | 埃克希金医药品有限公司 | 芳基磺酰胺盐ccr3拮抗剂 |
| US20120125711A1 (en) * | 2010-11-24 | 2012-05-24 | Stahr Richard E | Sound absorbing panel and system |
| EP2648676A4 (en) | 2010-12-06 | 2016-05-04 | Follica Inc | METHODS FOR TREATING CALVITIA AND PROMOTING HAIR GROWTH |
| WO2012080050A1 (en) | 2010-12-14 | 2012-06-21 | F. Hoffmann-La Roche Ag | Solid forms of a phenoxybenzenesulfonyl compound |
| US9540443B2 (en) | 2011-01-26 | 2017-01-10 | Kolltan Pharmaceuticals, Inc. | Anti-kit antibodies |
| WO2012106299A1 (en) | 2011-01-31 | 2012-08-09 | Celgene Corporation | Pharmaceutical compositions of cytidine analogs and methods of use thereof |
| AR085352A1 (es) | 2011-02-10 | 2013-09-25 | Idenix Pharmaceuticals Inc | Inhibidores macrociclicos de serina proteasa, sus composiciones farmaceuticas y su uso para tratar infecciones por hcv |
| JP2014509648A (ja) | 2011-03-28 | 2014-04-21 | メイ プハルマ,インコーポレーテッド | (α−置換シクロアルキルアミノ及びヘテロシクリルアミノ)ピリミジニル及び1,3,5−トリアジニルベンズイミダゾール、その医薬組成物、並びに増殖性疾患の治療におけるそれらの使用 |
| WO2012135166A1 (en) | 2011-03-28 | 2012-10-04 | Pathway Therapeutics Inc. | (fused ring arylamino and heterocyclylamino) pyrimidynyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases |
| ES2608967T3 (es) | 2011-03-28 | 2017-04-17 | Mei Pharma, Inc. | (Aralquilamino sustituido en alfa y heteroarilalquilamino)pirimidinil y 1,3,5-triazinil benzimidazoles, composiciones farmacéuticas que los contienen, y estos compuestos para usar en el tratamiento de enfermedades proliferativas |
| US20120252721A1 (en) | 2011-03-31 | 2012-10-04 | Idenix Pharmaceuticals, Inc. | Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor |
| MX2013015373A (es) | 2011-06-23 | 2014-02-11 | Map Pharmaceuticals Inc | Nuevos analogos de fluoroergolina. |
| WO2013037482A1 (en) | 2011-09-15 | 2013-03-21 | Phenex Pharmaceuticals Ag | Farnesoid x receptor agonists for cancer treatment and prevention |
| RS54936B1 (sr) | 2011-10-14 | 2016-11-30 | Ambit Biosciences Corp | Heterociklična jedinjenja i njihova upotreba kao modulatora receptora tirozin kinaza tipa iii |
| SG11201403434YA (en) | 2011-12-19 | 2014-09-26 | Map Pharmaceuticals Inc | Novel iso-ergoline derivatives |
| CA2859175A1 (en) | 2011-12-21 | 2013-06-27 | Map Pharmaceuticals, Inc. | Novel neuromodulatory compounds |
| WO2013130600A1 (en) | 2012-02-29 | 2013-09-06 | Ambit Biosciences Corporation | Solid forms comprising optically active pyrazolylaminoquinazoline, compositions thereof, and uses therewith |
| KR20140138293A (ko) | 2012-03-16 | 2014-12-03 | 액시킨 파마수티컬스 인코포레이티드 | 3,5-다이아미노피라졸 키나아제 억제제 |
| EP3438087A1 (en) | 2012-05-02 | 2019-02-06 | Boehringer Ingelheim International GmbH | Substituted 3-haloallylamine inhibitors of ssao and uses thereof |
| EP3406598B1 (en) | 2012-06-14 | 2020-01-29 | Mayo Foundation for Medical Education and Research | Pyrazole derivatives as inhibitors of stat3 |
| US9012640B2 (en) | 2012-06-22 | 2015-04-21 | Map Pharmaceuticals, Inc. | Cabergoline derivatives |
| CN116574185A (zh) | 2012-07-25 | 2023-08-11 | 塞尔德克斯医疗公司 | 抗kit抗体及其用途 |
| US9074186B2 (en) | 2012-08-15 | 2015-07-07 | Boston Medical Center Corporation | Production of red blood cells and platelets from stem cells |
| CN104781240A (zh) | 2012-09-07 | 2015-07-15 | 埃克希金医药品有限公司 | 同位素富集的芳基磺酰胺ccr3拮抗剂 |
| WO2014055647A1 (en) | 2012-10-03 | 2014-04-10 | Mei Pharma, Inc. | (sulfinyl and sulfonyl benzimidazolyl) pyrimidines and triazines, pharmaceutical compositions thereof, and their use for treating proliferative diseases |
| WO2014074765A2 (en) | 2012-11-08 | 2014-05-15 | Summa Health System | Vitamin c, vitamin k, a polyphenol, and combinations thereof for wound healing |
| CN104955801B (zh) | 2012-11-30 | 2017-10-31 | 诺沃梅迪科斯有限公司 | 取代的二芳基磺酰胺及其用途 |
| US9169214B2 (en) | 2012-12-21 | 2015-10-27 | The Board Of Trustees Of The Leland Stanford Junior University | Compounds and compositions that bind and stabilize transthyretin and their use for inhibiting transthyretin amyloidosis and protein-protein interactions |
| BR112015014964A2 (pt) | 2012-12-21 | 2017-07-11 | Map Pharmaceuticals Inc | novos derivados de metisergida |
| CA2897665A1 (en) | 2013-01-11 | 2014-07-17 | Mayo Foundation For Medical Education And Research | Vitamins c and k for treating polycystic diseases |
| SG11201509982UA (ja) | 2013-06-06 | 2016-04-28 | Igenica Biotherapeutics Inc | |
| US9909269B2 (en) * | 2013-07-07 | 2018-03-06 | 4Silence B.V. | Diffractor for diffracting sound |
| KR20160055170A (ko) | 2013-08-30 | 2016-05-17 | 암비트 바이오사이언시즈 코포레이션 | 바이아릴 아세트아미드 화합물 및 이의 사용 방법 |
| NZ631142A (en) | 2013-09-18 | 2016-03-31 | Axikin Pharmaceuticals Inc | Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors |
| EP3046924A1 (en) | 2013-09-20 | 2016-07-27 | IDENIX Pharmaceuticals, Inc. | Hepatitis c virus inhibitors |
| US10272117B2 (en) | 2014-02-24 | 2019-04-30 | Celgene Corporation | Methods of using an activator of cereblon for neural cell expansion and the treatment of central nervous system disorders |
| GB201403775D0 (en) | 2014-03-04 | 2014-04-16 | Kymab Ltd | Antibodies, uses & methods |
| US20170066779A1 (en) | 2014-03-05 | 2017-03-09 | Idenix Pharmaceuticals Llc | Solid forms of a flaviviridae virus inhibitor compound and salts thereof |
| KR102409739B1 (ko) | 2014-03-20 | 2022-06-17 | 카펠라 테라퓨틱스, 인크. | 암 치료용의 erbb 티로신 키나제 억제제로서의 벤즈이미다졸 유도체 |
| KR102416358B1 (ko) | 2014-03-20 | 2022-07-07 | 카펠라 테라퓨틱스, 인크. | 암 치료용의 erbb 티로신 키나제 억제제로서의 벤즈이미다졸 유도체 |
| ES2751652T3 (es) | 2014-05-12 | 2020-04-01 | Conatus Pharmaceuticals Inc | Tratamiento con inhibidor de caspasa emricasan de las complicaciones por las enfermedades hepáticas crónicas |
| SG10201912986PA (en) | 2014-05-28 | 2020-02-27 | Agenus Inc | Anti-gitr antibodies and methods of use thereof |
| US9527815B2 (en) | 2014-06-18 | 2016-12-27 | Biotheryx, Inc. | Hydroxypyridone derivatives, pharmaceutical compositions thereof, and their therapeutic use for treating inflammatory, neurodegenerative, or immune-mediated diseases |
| US9499514B2 (en) | 2014-07-11 | 2016-11-22 | Celgene Corporation | Antiproliferative compounds and methods of use thereof |
| US20160045609A1 (en) | 2014-08-14 | 2016-02-18 | Mamoun M. Alhamadsheh | Conjugation of pharmaceutically active agents with transthyretin ligands through adjustable linkers to increase serum half-life |
| BR112017004708A2 (pt) | 2014-09-12 | 2017-12-05 | Tobira Therapeutics Inc | terapia de combinação de cenicriviroc para o tratamento de fibrose |
| WO2016065264A1 (en) | 2014-10-24 | 2016-04-28 | Biogen Ma Inc. | Diterpenoid derivatives and methods of use thereof |
| JP7211703B2 (ja) | 2014-12-22 | 2023-01-24 | ザ ロックフェラー ユニバーシティー | 抗mertkアゴニスト抗体及びその使用 |
| US9546163B2 (en) | 2014-12-23 | 2017-01-17 | Axikin Pharmaceuticals, Inc. | 3,5-diaminopyrazole kinase inhibitors |
| JP6856532B2 (ja) | 2015-01-20 | 2021-04-07 | エックスオーシー ファーマシューティカルズ インコーポレイテッドXoc Pharmaceuticals, Inc | エルゴリン化合物およびその使用 |
| WO2016119700A1 (en) | 2015-01-28 | 2016-08-04 | Jn Therapeutics | Substituted imidazo [1, 2-a] pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof |
| MX2017011194A (es) | 2015-03-03 | 2018-04-10 | Kymab Ltd | Anticuerpos, usos y métodos. |
| MA44594B1 (fr) | 2015-05-29 | 2020-09-30 | Memorial Sloan Kettering Cancer Center | Anticorps anti-ctla-4 et méthodes d'utilisation de ceux-ci |
| EA036837B1 (ru) | 2015-06-23 | 2020-12-25 | Нейрокрин Байосайенсиз, Инк. | Ингибиторы vmat2 для лечения неврологических заболеваний или расстройств |
| CN114605548A (zh) | 2015-09-01 | 2022-06-10 | 艾吉纳斯公司 | 抗-pd-1抗体及其使用方法 |
| MY193767A (en) | 2015-10-30 | 2022-10-27 | Neurocrine Biosciences Inc | Valbenazine salts and polymorphs thereof |
| WO2017079566A1 (en) | 2015-11-05 | 2017-05-11 | Conatus Pharmaceuticals, Inc. | Caspase inhibitors for use in the treatment of liver cancer |
| JP7011596B2 (ja) | 2015-12-02 | 2022-02-10 | アストライア セラピューティクス, エルエルシー | ピペリジニルノシセプチン受容体化合物 |
| US10112924B2 (en) | 2015-12-02 | 2018-10-30 | Astraea Therapeutics, Inc. | Piperdinyl nociceptin receptor compounds |
| CN108925135B (zh) | 2015-12-23 | 2025-09-19 | 纽罗克里生物科学有限公司 | 制备(S)-(2R,3R,11bR)-3-异丁基-9,10-二甲氧基-2,3,4,6,7,11b-六氢-1H-吡啶并[2,1-a]异喹啉-2-基2-氨基-3-甲基丁酸酯二(4-甲基苯磺酸盐)的合成方法 |
| JP2019500397A (ja) | 2015-12-31 | 2019-01-10 | クオナトウス ファーマシューティカルズ,インコーポレイテッド | カスパーゼ阻害剤を肝疾患の治療に使用する方法 |
| EP3399981B1 (en) | 2016-01-08 | 2023-08-02 | Celgene Corporation | Solid forms of 2-(4-chlorophenyl)-n-((2-2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl) methyl)-2,2-difluoroacetamide, and their pharmaceutical compositions and uses |
| CN108430473B (zh) | 2016-01-08 | 2021-08-31 | 细胞基因公司 | 抗增殖化合物以及其药物组合物和用途 |
| US10960013B2 (en) | 2016-03-04 | 2021-03-30 | East Carolina University | J-series prostaglandin-ethanolamides as novel therapeutics for skin and/or oral disorders |
| US10407437B2 (en) | 2016-03-08 | 2019-09-10 | Los Gatos Pharmaceuticals, Inc. | Camptothecin derivatives and uses thereof |
| EP3426301A4 (en) | 2016-03-08 | 2019-11-06 | Los Gatos Pharmaceuticals, Inc. | VERBUNDNANOPARTICLES AND USES THEREOF |
| WO2017180589A1 (en) | 2016-04-11 | 2017-10-19 | Auspex Pharmaceuticals, Inc. | Deuterated ketamine derivatives |
| ES2939373T3 (es) | 2016-05-13 | 2023-04-21 | Pasteur Institut | Inhibición de los receptores de acetilcolina nicotínicos beta-2 para tratar la patología de la enfermedad de Alzheimer |
| TWI753910B (zh) | 2016-05-16 | 2022-02-01 | 美商拜歐斯瑞克斯公司 | 吡啶硫酮、其醫藥組合物及其治療增生性、炎性、神經退化性或免疫介導疾病之治療用途 |
| TWI781934B (zh) | 2016-05-27 | 2022-11-01 | 美商艾吉納斯公司 | 抗-tim-3抗體及其使用方法 |
| DE102016111064A1 (de) * | 2016-06-16 | 2017-12-21 | Vossloh-Werke Gmbh | Elastisches Element für einen Befestigungspunkt für eine Schiene für Schienenfahrzeuge und Befestigungspunkt |
| CN106087611B (zh) * | 2016-06-20 | 2019-07-12 | 勾厚渝 | 轨道交通构件 |
| AU2017292184A1 (en) | 2016-07-08 | 2019-02-07 | Staten Biotechnology B.V. | Anti-Apoc3 antibodies and methods of use thereof |
| US10919904B2 (en) | 2016-08-17 | 2021-02-16 | North Carolina State University | Northern-southern route to synthesis of bacteriochlorins |
| CN109982687A (zh) | 2016-09-19 | 2019-07-05 | 梅制药公司 | 联合疗法 |
| SG10201912663YA (en) | 2016-10-11 | 2020-03-30 | Agenus Inc | Anti-lag-3 antibodies and methods of use thereof |
| EP3534947A1 (en) | 2016-11-03 | 2019-09-11 | Kymab Limited | Antibodies, combinations comprising antibodies, biomarkers, uses & methods |
| WO2018083538A1 (en) | 2016-11-07 | 2018-05-11 | Neuracle Scienc3 Co., Ltd. | Anti-family with sequence similarity 19, member a5 antibodies and method of use thereof |
| WO2018089692A1 (en) | 2016-11-09 | 2018-05-17 | Phloronol, Inc. | Eckol derivatives, methods of synthesis and uses thereof |
| TW201828932A (zh) | 2016-11-09 | 2018-08-16 | 美商諾沃麥迪斯有限責任公司 | 1,1-二甲基雙胍之亞硝酸鹽、醫藥組合物及使用方法 |
| WO2018102252A1 (en) | 2016-11-30 | 2018-06-07 | North Carolina State University | Methods for making bacteriochlorin macrocycles comprising an annulated isocyclic ring and related compounds |
| EP3548007A4 (en) | 2016-12-01 | 2020-08-12 | Ignyta, Inc. | METHOD OF TREATMENT OF CANCER |
| TW202345829A (zh) | 2016-12-02 | 2023-12-01 | 美商紐羅克里生物科學有限公司 | 戊苯那嗪(valbenazine)於治療精神分裂症或情感性精神分裂症之用途 |
| WO2018106862A1 (en) | 2016-12-07 | 2018-06-14 | Agenus Inc. | Anti-ctla-4 antibodies and methods of use thereof |
| JP7106538B2 (ja) | 2016-12-07 | 2022-07-26 | アジェナス インコーポレイテッド | 抗体およびその使用方法 |
| WO2018140092A1 (en) | 2017-01-27 | 2018-08-02 | Obrien Christopher F | Methods for the administration of certain vmat2 inhibitors |
| US10961276B2 (en) | 2017-02-17 | 2021-03-30 | CAMRIS International, Inc. | Universal antivenom |
| KR102874295B1 (ko) | 2017-02-17 | 2025-10-20 | 에이도스 테라퓨틱스, 인코포레이티드 | Ag-10, 이의 중간체, 및 이의 염을 제조하는 방법 |
| WO2018164996A1 (en) | 2017-03-06 | 2018-09-13 | Neurocrine Biosciences, Inc. | Dosing regimen for valbenazine |
| BR112019020185A2 (pt) | 2017-03-27 | 2020-06-02 | Celgene Corporation | Métodos e composições para redução da imunogenicidade |
| JP7297672B2 (ja) | 2017-04-13 | 2023-06-26 | アジェナス インコーポレイテッド | 抗cd137抗体およびその使用方法 |
| JP2020517242A (ja) | 2017-04-21 | 2020-06-18 | スターテン・バイオテクノロジー・ベー・フェー | 抗ApoC3抗体およびその使用方法 |
| WO2018200605A1 (en) | 2017-04-26 | 2018-11-01 | Neurocrine Biosciences, Inc. | Use of valbenazine for treating levodopa-induced dyskinesia |
| RS64576B1 (sr) | 2017-05-01 | 2023-10-31 | Agenus Inc | Anti-tigit antitela i postupci njihove primene |
| JOP20190219A1 (ar) | 2017-05-09 | 2019-09-22 | Cardix Therapeutics LLC | تركيبات صيدلانية وطرق لعلاج أمراض القلب والأوعية الدموية |
| US10085999B1 (en) | 2017-05-10 | 2018-10-02 | Arixa Pharmaceuticals, Inc. | Beta-lactamase inhibitors and uses thereof |
| JP7076059B2 (ja) | 2017-06-27 | 2022-05-27 | ニューラクル サイエンス カンパニー リミテッド | 抗fam19a5抗体及びその用途 |
| JP7012384B2 (ja) | 2017-06-27 | 2022-02-14 | ニューラクル サイエンス カンパニー リミテッド | 癌治療のための抗fam19a5抗体の用途 |
| EP3645039A4 (en) | 2017-06-27 | 2021-05-05 | Neuracle Science Co., Ltd | USE OF ANTI-FAM19A5 ANTIBODIES TO TREAT FIBROSIS |
| WO2019003162A1 (en) | 2017-06-27 | 2019-01-03 | Neuracle Science Co., Ltd. | USE OF ANTIBODIES DIRECTED AGAINST A SIMILARITY FAMILY OF SEQUENCE 19, MEMBER A5, FOR THE TREATMENT OF GLAUCOMA |
| AU2018324070B2 (en) | 2017-09-01 | 2023-05-18 | East Carolina University | Compounds, compositions, kits, and methods for activating immune cells and/or an immune system response |
| ES3024958T3 (en) | 2017-09-21 | 2025-06-05 | Neurocrine Biosciences Inc | High dosage valbenazine formulation and compositions, methods, and kits related thereto |
| US12072339B2 (en) | 2017-10-02 | 2024-08-27 | Neuracle Science Co., Ltd. | Use of anti-family with sequence similarity 19, member A5 antibodies for the treatment and diagnosis of mood disorders |
| WO2019071021A2 (en) | 2017-10-04 | 2019-04-11 | The Regents Of The University Of California | IMMUNOMODULATORY OLIGOSACCHARIDES |
| KR20250070134A (ko) | 2017-10-10 | 2025-05-20 | 뉴로크린 바이오사이언시즈 인코퍼레이티드 | 특정 vmat2 억제제의 투여 방법 |
| JP2021502959A (ja) | 2017-10-10 | 2021-02-04 | ニューロクライン バイオサイエンシーズ,インコーポレイテッド | 特定のvmat2インヒビターを投与するための方法 |
| KR20200074975A (ko) | 2017-10-31 | 2020-06-25 | 스태튼 바이오테크놀로지 비.브이. | 항-ApoC3 항체 및 이의 사용 방법 |
| WO2019139871A1 (en) | 2018-01-10 | 2019-07-18 | Cura Therapeutics Llc | Pharmaceutical compositions comprising dicarboxylic acids and their therapeutic applications |
| JP7395480B2 (ja) | 2018-01-10 | 2023-12-11 | クラ セラピューティクス, エルエルシー | フェニルスルホンアミドを含む薬学的組成物、及びそれらの治療的適用 |
| US11058668B2 (en) | 2018-03-23 | 2021-07-13 | Eidos Therapeutics, Inc. | Methods of treating TTR amyloidosis using AG10 |
| CA3097999A1 (en) | 2018-04-24 | 2019-10-31 | Neuracle Science Co., Ltd. | Use of anti-family with sequence similarity 19, member a5 antibodies for the treatment of neuropathic pain |
| CA3098805A1 (en) | 2018-05-10 | 2019-11-14 | Neuracle Science Co., Ltd. | Anti-family with sequence similarity 19, member a5 antibodies and method of use thereof |
| MX2020013004A (es) | 2018-06-14 | 2021-02-17 | Neurocrine Biosciences Inc | Compuestos inhibidores del transportador de monoamina 2 (vmat2), composiciones, y metodos relacionados con los mismos. |
| CN108533609B (zh) * | 2018-06-27 | 2020-03-10 | 贵州筑信达创科技有限公司 | 导轨及滑动件的组合结构 |
| CN108836091B (zh) * | 2018-06-27 | 2020-12-04 | 贵州筑信达创科技有限公司 | 导轨 |
| US11447497B2 (en) | 2018-06-29 | 2022-09-20 | Histogen, Inc. | (S)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid derivatives and related compounds as caspase inhibitors for treating cardiovascular diseases |
| KR102767692B1 (ko) | 2018-07-20 | 2025-02-17 | 피에르 파브르 메디카먼트 | Vista의 수용체 |
| SG11202100303QA (en) | 2018-08-15 | 2021-02-25 | Neurocrine Biosciences Inc | Methods for the administration of certain vmat2 inhibitors |
| IL325404A (en) | 2018-08-17 | 2026-02-01 | Eidos Therapeutics Inc | Spice formulations containing 3-(3-(5,3-dimethyl-1h-pyrazol-4-yl)propoxy)-4-fluorobenzoic acid |
| WO2020070678A2 (en) | 2018-10-03 | 2020-04-09 | Staten Biotechnology B.V. | Antibodies specific for human and cynomolgus apoc3 and methods of use thereof |
| WO2020079595A1 (en) | 2018-10-16 | 2020-04-23 | Neuracle Science Co., Ltd. | Use of anti-fam19a5 antibodies |
| EP3880231A1 (en) | 2018-11-16 | 2021-09-22 | NeoImmuneTech, Inc. | Method of treating a tumor with a combination of il-7 protein and an immune checkpoint inhibitor |
| WO2020118042A1 (en) | 2018-12-05 | 2020-06-11 | Jacobs Wagner Christine | Borrelia burgdorferi peptidoglycan as a diagnostic and target for therapeutic intervention of lyme disease-related pathologies |
| KR20200071198A (ko) | 2018-12-10 | 2020-06-19 | 네오이뮨텍, 인코퍼레이티드 | Nrf2 발현 조절 기반 T 세포 항암면역치료법 |
| JP7407461B2 (ja) | 2018-12-19 | 2024-01-04 | シャイ・セラピューティクス・エルエルシー | がん、炎症性疾患、ras病、及び線維性疾患の処置のためのrasスーパーファミリーと相互作用する化合物 |
| JP7239216B2 (ja) | 2018-12-27 | 2023-03-14 | ニューラクル サイエンス カンパニー リミテッド | 粥状硬化症を治療するための抗fam19a5抗体の使用 |
| CA3117619A1 (en) | 2019-01-02 | 2020-07-09 | Neuracle Science Co., Ltd. | Anti-family with sequence similarity 19, member a5 antibodies and method of use thereof |
| TWI839461B (zh) | 2019-02-06 | 2024-04-21 | 美商戴斯阿爾法股份有限公司 | Il-17a調節物及其用途 |
| MA55080A (fr) | 2019-02-26 | 2022-01-05 | Inspirna Inc | Anticorps anti-mertk à affinité élevée et utilisations associées |
| PL3935042T3 (pl) | 2019-03-07 | 2024-11-04 | Nobo Medicine Inc. | Inhibitory kaspazy i sposoby ich zastosowania |
| EP3959292B1 (en) | 2019-05-20 | 2025-07-02 | NIRvana Sciences Inc. | Narrow emission dyes, compositions comprising same, and methods for making and using same |
| US20220249707A1 (en) | 2019-05-20 | 2022-08-11 | Nirvana Sciences Inc. | Narrow emission dyes, compositions comprising same, and methods for making and using same |
| CA3146159A1 (en) | 2019-07-11 | 2021-01-14 | Cura Therapeutics, Llc | Phenyl compounds and pharmaceutical compositions thereof, and their therapeutic applications |
| EP3997068A1 (en) | 2019-07-11 | 2022-05-18 | Cura Therapeutics, LLC | Sulfone compounds and pharmaceutical compositions thereof, and their therapeutic applications for the treatment of neurodegenerative diseases |
| US10940141B1 (en) | 2019-08-23 | 2021-03-09 | Neurocrine Biosciences, Inc. | Methods for the administration of certain VMAT2 inhibitors |
| TW202122420A (zh) | 2019-08-30 | 2021-06-16 | 美商艾吉納斯公司 | 抗cd96抗體及其使用方法 |
| IL291345B2 (en) | 2019-09-16 | 2024-04-01 | Dice Alpha Inc | Il-17a modulators and uses thereof |
| KR102337657B1 (ko) * | 2019-11-06 | 2021-12-09 | 한국철도기술연구원 | 철도진동저감용 조립식 블록 및 이를 이용한 블록 구조물 |
| IL294663A (en) | 2020-01-13 | 2022-09-01 | Neoimmunetech Inc | Method of treating a tumor with a combination of il-7 protein and a bispecific antibody |
| CN113136745B (zh) * | 2020-01-17 | 2024-10-25 | 洛阳双瑞橡塑科技有限公司 | 一种轨道道床吸音减振装置 |
| WO2021151001A1 (en) | 2020-01-22 | 2021-07-29 | Outpace Bio, Inc. | Chimeric polypeptides |
| AU2021217373A1 (en) | 2020-02-05 | 2022-08-04 | Neoimmunetech, Inc. | Method of treating a solid tumor with a combination of an IL-7 protein and CAR-bearing immune cells |
| US12006643B2 (en) * | 2020-05-27 | 2024-06-11 | Mute Wall Systems, Inc. | Sound dampening barrier wall |
| WO2021242970A1 (en) | 2020-05-29 | 2021-12-02 | Boulder Bioscience Llc | Methods for improved endovascular thrombectomy using 3,3'-diindolylmethane |
| EP4168414A1 (en) | 2020-06-18 | 2023-04-26 | Shy Therapeutics LLC | Substituted thienopyrimidines that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease |
| JP7828905B2 (ja) | 2020-06-30 | 2026-03-12 | プロセッタ バイオサイエンシズ, インク. | イソキノリン誘導体、合成の方法及びそれらの使用 |
| WO2022061348A1 (en) | 2020-09-16 | 2022-03-24 | Biotheryx, Inc. | Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications |
| WO2022087335A1 (en) | 2020-10-23 | 2022-04-28 | Biotheryx, Inc. | Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications |
| WO2022094475A1 (en) | 2020-11-02 | 2022-05-05 | Neoimmunetech, Inc. | Use of interleukin-7 for the treatment of coronavirus |
| CA3195594A1 (en) | 2020-11-05 | 2022-05-12 | Byung Ha Lee | Method of treating a tumor with a combination of an il-7 protein and a nucleotide vaccine |
| CN112712784B (zh) * | 2020-11-30 | 2024-12-31 | 南京华秦光声科技有限责任公司 | 一种低频宽带平板吸声结构 |
| TW202237580A (zh) | 2020-12-14 | 2022-10-01 | 美商拜歐斯瑞克斯公司 | Pde4降解劑、醫藥組合物及治療應用 |
| WO2022165000A1 (en) | 2021-01-27 | 2022-08-04 | Shy Therapeutics, Llc | Methods for the treatment of fibrotic disease |
| EP4284377A1 (en) | 2021-01-27 | 2023-12-06 | Shy Therapeutics LLC | Methods for the treatment of fibrotic disease |
| CR20230472A (es) | 2021-03-10 | 2024-03-21 | Dice Molecules Sv Inc | Inhibidores de integrina alpha v beta 6 y alpha v beta 1 y sus usos |
| EP4326721A1 (en) | 2021-04-22 | 2024-02-28 | Protego Biopharma, Inc. | Spirocyclic imidazolidinones and imidazolidinediones for treatment of light chain amyloidosis |
| WO2022251533A1 (en) | 2021-05-27 | 2022-12-01 | Protego Biopharma, Inc. | Heteroaryl diamide ire1/xbp1s activators |
| WO2022251644A1 (en) | 2021-05-28 | 2022-12-01 | Lyell Immunopharma, Inc. | Nr4a3-deficient immune cells and uses thereof |
| KR20240027676A (ko) | 2021-06-02 | 2024-03-04 | 라이엘 이뮤노파마, 인크. | Nr4a3-결핍 면역 세포 및 이의 용도 |
| JP2024522213A (ja) | 2021-06-14 | 2024-06-11 | アルジェニクス ビーブイ | 抗il-9抗体及びその使用方法 |
| AU2022292649A1 (en) | 2021-06-16 | 2024-01-04 | Biotheryx, Inc. | Sos1 protein degraders, pharmaceutical compositions thereof, and their therapeutic applications |
| WO2022266249A1 (en) | 2021-06-16 | 2022-12-22 | Biotheryx, Inc. | Kras protein degraders, pharmaceutical compositions thereof, and their therapeutic applications |
| US20240277857A1 (en) | 2021-09-29 | 2024-08-22 | Nbios, Inc. | Coiled-coil fusion protein |
| US12017997B2 (en) | 2021-10-22 | 2024-06-25 | Prosetta Biosciences, Inc. | Host-targeted pan-respiratory antiviral small molecule therapeutics |
| CA3237696A1 (en) | 2021-11-08 | 2023-05-11 | Progentos Therapeutics, Inc. | Platelet-derived growth factor receptor (pdgfr) alpha inhibitors and uses thereof |
| KR20240130705A (ko) | 2021-12-30 | 2024-08-29 | 네오이뮨텍, 인코퍼레이티드 | Il-7 단백질 및 vegf 길항제의 조합으로 종양을 치료하는 방법 |
| US11932665B2 (en) | 2022-01-03 | 2024-03-19 | Lilac Therapeutics, Inc. | Cyclic thiol prodrugs |
| EP4433040A4 (en) | 2022-01-03 | 2025-11-12 | Lilac Therapeutics Inc | ACYCLIC THIOL PRODRUGS |
| AU2022441090A1 (en) | 2022-02-17 | 2024-08-22 | Novelty Nobility Inc. | Antibody-drug conjugate. |
| JP2025507621A (ja) | 2022-03-02 | 2025-03-21 | ミトパワー, インク. | ニコチン酸及びリボースから誘導体化した新規プロドラッグ |
| AR128918A1 (es) | 2022-03-30 | 2024-06-26 | Biomarin Pharm Inc | Oligonucleótidos que omiten el exón 51 de distrofina y sus aplicaciones |
| GB2619907A (en) | 2022-04-01 | 2023-12-27 | Kanna Health Ltd | Novel crystalline salt forms of mesembrine |
| WO2023201282A1 (en) | 2022-04-14 | 2023-10-19 | Bristol-Myers Squibb Company | Novel gspt1 compounds and methods of use of the novel compounds |
| WO2023215781A1 (en) | 2022-05-05 | 2023-11-09 | Biomarin Pharmaceutical Inc. | Method of treating duchenne muscular dystrophy |
| TW202413356A (zh) | 2022-05-10 | 2024-04-01 | 美商拜歐斯瑞克斯公司 | Cdk蛋白降解劑、藥物組合物及其治療應用 |
| KR20250027283A (ko) | 2022-05-19 | 2025-02-25 | 라이엘 이뮤노파마, 인크. | nr4a3을 표적하는 폴리뉴클레오타이드 및 이의 용도 |
| CN120303264A (zh) | 2022-09-09 | 2025-07-11 | 医诺康治疗公司 | CK1α和双重CK1α/GSPT1降解化合物 |
| WO2024073473A1 (en) | 2022-09-30 | 2024-04-04 | Boulder Bioscience Llc | Compositions comprising 3,3'-diindolylmethane for treating non-hemorrhagic closed head injury |
| US20240209100A1 (en) | 2022-10-21 | 2024-06-27 | Diagonal Therapeutics Inc. | Heteromeric agonistic antibodies to il-18 receptor |
| WO2024092043A1 (en) | 2022-10-26 | 2024-05-02 | Protego Biopharma, Inc. | Spirocycle containing pyridine compounds |
| EP4608838A1 (en) | 2022-10-26 | 2025-09-03 | Protego Biopharma, Inc. | Spirocycle containing pyridone compounds |
| EP4608839A1 (en) | 2022-10-26 | 2025-09-03 | Protego Biopharma, Inc. | Spirocycle containing bicyclic heteroaryl compounds |
| WO2024102722A1 (en) | 2022-11-07 | 2024-05-16 | Neoimmunetech, Inc. | Methods of treating a tumor with an unmethylated mgmt promoter |
| WO2024118810A1 (en) | 2022-11-30 | 2024-06-06 | Protego Biopharma, Inc. | Cyclic pyrazole diamide ire1/xbp1s activators |
| WO2024118801A1 (en) | 2022-11-30 | 2024-06-06 | Protego Biopharma, Inc. | Linear heteroaryl diamide ire1/xbp1s activators |
| KR102870410B1 (ko) * | 2022-12-09 | 2025-10-16 | 한국전자기술연구원 | 방음재 및 소음 제어 시스템 |
| WO2024194685A2 (en) | 2023-03-17 | 2024-09-26 | Oxitope Pharma B.V. | Anti-phosphocholine antibodies and methods of use thereof |
| WO2024194686A2 (en) | 2023-03-17 | 2024-09-26 | Oxitope Pharma B.V. | Anti-phosphocholine antibodies and methods of use thereof |
| US20240383990A1 (en) | 2023-04-07 | 2024-11-21 | Diagonal Therapeutics Inc. | Hinge-modified bispecific antibodies |
| US20250002588A1 (en) | 2023-04-07 | 2025-01-02 | Diagonal Therapeutics Inc. | Bispecific agonistic antibodies to activin a receptor like type 1 (alk1) |
| WO2024226471A2 (en) | 2023-04-24 | 2024-10-31 | Biomarin Pharmaceutical Inc. | Compositions and methods for treating stxbp1 disorders |
| US20240368596A1 (en) | 2023-05-05 | 2024-11-07 | Biomarin Pharmaceutical Inc. | Dystrophin exon skipping oligonucleotides |
| CN121263415A (zh) | 2023-05-09 | 2026-01-02 | 普罗根托斯治疗公司 | 杂环化合物及其用途 |
| CN121219320A (zh) | 2023-05-19 | 2025-12-26 | 达科纳治疗有限公司 | 针对il12受体的双特异性激动性抗体 |
| WO2025010272A1 (en) | 2023-07-03 | 2025-01-09 | Neoimmunetech, Inc. | Heterodimeric fc molecules and uses thereof |
| US20250101101A1 (en) | 2023-09-01 | 2025-03-27 | iTeos Belgium SA | Anti-trem2 antibodies and methods of use |
| WO2025063888A1 (en) | 2023-09-19 | 2025-03-27 | Kancure Pte. Ltd. | Survivin-targeted compounds |
| US20250122182A1 (en) | 2023-09-27 | 2025-04-17 | Isosterix, Inc. | MYST Inhibitors |
| WO2025085416A1 (en) | 2023-10-16 | 2025-04-24 | Bristol-Myers Squibb Company | Gspt1 compounds and methods of use of the compounds |
| AU2024366926A1 (en) | 2023-10-23 | 2026-03-12 | Diagonal Therapeutics Inc. | Heteromeric agonistic antibodies to il-18 receptor |
| GB2636969A (en) | 2023-11-24 | 2025-07-09 | Ontrack Therapeutics Ltd | Novel crystalline salt forms |
| WO2025133707A1 (en) | 2023-12-19 | 2025-06-26 | Vectory Therapeutics B.V. | Anti-tdp-43 antibodies and uses thereof |
| WO2025147691A1 (en) | 2024-01-04 | 2025-07-10 | Innovo Therapeutics, Inc. | Compositions and methods for degrading aryl hydrocarbon receptor nuclear translocator protein |
| WO2025179161A1 (en) | 2024-02-21 | 2025-08-28 | Innovo Therapeutics, Inc. | Protein degrading compounds |
| WO2025201633A1 (en) | 2024-03-26 | 2025-10-02 | Chen Gefei | An agent for reducing amyloid formation |
| WO2025255341A1 (en) | 2024-06-05 | 2025-12-11 | Protego Biopharma, Inc. | Tetrahydrofuranyl ire1/xbp1s activators |
| WO2026080752A2 (en) | 2024-10-09 | 2026-04-16 | Diagonal Therapeutics Inc. | De novo antibodies to activin a receptor like type 1 (alk1) |
| WO2026080748A2 (en) | 2024-10-09 | 2026-04-16 | Diagonal Therapeutics Inc. | Bone morphogenetic protein receptor type 2 (bmprii) antibodies |
| WO2026080757A2 (en) | 2024-10-09 | 2026-04-16 | Diagonal Therapeutics Inc. | Activin receptor type ii a/b (actriia/b) antibodies |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3991848A (en) * | 1974-08-16 | 1976-11-16 | Frigitemp | Acoustical board |
| US4142468A (en) * | 1976-04-20 | 1979-03-06 | Charles Birnstiel | Elevated rail transit guideway with noise attenuators |
| US4093120A (en) | 1977-01-24 | 1978-06-06 | Park Rubber Company | Railroad crossing structure |
| DE7711191U1 (de) | 1977-04-07 | 1978-09-28 | Straetner Geb. Buss, Anita, 4300 Essen | Fahrbahnplatte fuer schienengleiche bahnuebergaenge |
| DE2727644C2 (de) * | 1977-06-20 | 1983-06-30 | Gummiwerk Kraiburg Elastik Gmbh & Co, 8261 Tittmoning | Schienengleicher Bahnübergang |
| DE3602313A1 (de) * | 1986-01-27 | 1987-07-30 | Clouth Gummiwerke Ag | Schallabsorbierender laermschutz insbesondere fuer schotterlose gleise |
| DE3827547C2 (de) * | 1988-08-13 | 2000-09-21 | Zueblin Ag | Schallabsorptionskonstruktion für schotterlose Eisenbahnoberbauten |
| US4960184A (en) * | 1989-11-09 | 1990-10-02 | Bruce Woodward | Sound absorbing structure |
| DE4243102A1 (en) | 1991-12-20 | 1993-07-01 | Bold Karl Gmbh & Co | Noise protection and sight wall with carrier girder construction |
| US5730548A (en) * | 1994-02-11 | 1998-03-24 | Autostrade-Concessioni E Costruzioni Autostrade S.P.A. | Deadening road pavement and method for its realization |
| DE4414566C2 (de) * | 1994-04-27 | 1997-11-20 | Freudenberg Carl Fa | Luftschalldämpfer |
| DE4417402A1 (de) | 1994-05-18 | 1995-11-23 | Gruenzweig & Hartmann Montage | Schallschutzeinrichtung zur Schalldämpfung und -dämmung an Gleiskörpern |
| NL194553C (nl) | 1994-06-06 | 2002-07-02 | Veldhoen Raalte B V | Inrichting voor de geluidsisolatie van een spoorbaan. |
| DE29515935U1 (de) * | 1995-10-07 | 1995-11-30 | Deutsche Asphalt GmbH, 63263 Neu-Isenburg | Schallabsorber für einen schotterlosen Eisenbahnoberbau |
| IT1293307B1 (it) * | 1997-07-09 | 1999-02-16 | Dieselbox Sa | Barriera antirumore a pannelli trasparenti,dotata di caratteristiche fonoisolanti e fonoassorbenti |
-
1997
- 1997-05-19 TW TW086106684A patent/TW345603B/zh not_active IP Right Cessation
- 1997-05-23 HU HU9903612A patent/HU221872B1/hu not_active IP Right Cessation
- 1997-05-23 DE DE59708955T patent/DE59708955D1/de not_active Expired - Lifetime
- 1997-05-23 JP JP54125697A patent/JP3822641B2/ja not_active Expired - Fee Related
- 1997-05-23 EP EP97922748A patent/EP0901536B1/de not_active Expired - Lifetime
- 1997-05-23 US US09/194,505 patent/US6253872B1/en not_active Expired - Lifetime
- 1997-05-23 AU AU28801/97A patent/AU738889B2/en not_active Ceased
- 1997-05-23 ES ES97922748T patent/ES2186891T3/es not_active Expired - Lifetime
- 1997-05-23 WO PCT/AT1997/000109 patent/WO1997045592A1/de not_active Ceased
- 1997-05-23 AT AT97922748T patent/ATE229595T1/de active
- 1997-05-23 CA CA002255946A patent/CA2255946C/en not_active Expired - Fee Related
- 1997-05-23 DK DK97922748T patent/DK0901536T3/da active
- 1997-05-23 CN CNB971950490A patent/CN100424268C/zh not_active Expired - Fee Related
-
1998
- 1998-11-30 NO NO19985600A patent/NO316078B1/no not_active IP Right Cessation
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007526412A (ja) * | 2004-03-05 | 2007-09-13 | グミュンドネル ファーチクタイル ゲゼルシャフト ミット ベシュレンクテル ハフトング ウント ツェーオー. カーゲー. | 騒音低減線路カバー |
| JP2008121395A (ja) * | 2006-11-14 | 2008-05-29 | Endeavor House Ltd | 伸縮性に優れた線路用吸音材 |
| JP2013508584A (ja) * | 2009-10-22 | 2013-03-07 | ユニフェルシテイト トウェンテ | 音回折器を有する道路 |
Also Published As
| Publication number | Publication date |
|---|---|
| TW345603B (en) | 1998-11-21 |
| JP3822641B2 (ja) | 2006-09-20 |
| HUP9903612A3 (en) | 2001-08-28 |
| WO1997045592A1 (de) | 1997-12-04 |
| NO985600D0 (no) | 1998-11-30 |
| CA2255946C (en) | 2006-03-14 |
| NO316078B1 (no) | 2003-12-08 |
| US6253872B1 (en) | 2001-07-03 |
| AU738889B2 (en) | 2001-09-27 |
| DE59708955D1 (de) | 2003-01-23 |
| EP0901536A1 (de) | 1999-03-17 |
| HU221872B1 (hu) | 2003-02-28 |
| DK0901536T3 (da) | 2003-04-07 |
| ES2186891T3 (es) | 2003-05-16 |
| EP0901536B1 (de) | 2002-12-11 |
| NO985600L (no) | 1998-11-30 |
| ATE229595T1 (de) | 2002-12-15 |
| CA2255946A1 (en) | 1997-12-04 |
| CN1219989A (zh) | 1999-06-16 |
| AU2880197A (en) | 1998-01-05 |
| HUP9903612A2 (hu) | 2000-02-28 |
| CN100424268C (zh) | 2008-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2000510921A (ja) | 軌道用の防音装置 | |
| US4358090A (en) | Sound barrier for highway and other traffic | |
| NZ230688A (en) | Steel rail with bonded acoustic damping medium | |
| JPH09111910A (ja) | 吸音性制振形材 | |
| CN115928511A (zh) | 一种适用于站城一体化综合开发的高等级减振轨道结构 | |
| KR101817142B1 (ko) | 소음 저감을 위한 하로교 u형 거더 및 그 시공 방법 | |
| US5655711A (en) | Prefabricated embedded railway track system | |
| EP1229167B1 (en) | Sound absorbing construction for track | |
| JP3440423B2 (ja) | 軌道敷設用路体構造 | |
| SU1633052A1 (ru) | Совмещенный с проезжей частью рельсовый путь | |
| JP2975407B2 (ja) | ゴムパット付き枕木の製法 | |
| NL9400910A (nl) | Samenstel voor de geluidsisolatie van een spoorbaan. | |
| CN116516740A (zh) | 道床谐振器、谐振系统、轨道系统及谐振器的安装方法 | |
| CN208995841U (zh) | 有砟轨道道床 | |
| JP3450309B2 (ja) | 軌道カバリング | |
| JPH09125321A (ja) | 鋼製壁高欄 | |
| JP2742766B2 (ja) | 並列する橋体隙間の遮蔽装置 | |
| JP2908295B2 (ja) | まくらぎの弾性支承装置 | |
| JPH11350401A (ja) | まくらぎ弾性支持装置及びこの装置を備えたまくらぎ | |
| JPH0715807U (ja) | ルーバーの取付構造 | |
| CN205223751U (zh) | 现代有轨电车新型隔振降噪柔性轨腰包覆件 | |
| JP4091836B2 (ja) | 鉄道用防音壁 | |
| JP2004042735A (ja) | 車両用スカート体 | |
| JP2580772Y2 (ja) | 軌道用騒音防止装置 | |
| JP2002089605A (ja) | 板バネによる衝撃吸収体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040521 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040521 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20040701 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20060523 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20060623 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090630 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100630 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110630 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110630 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120630 Year of fee payment: 6 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130630 Year of fee payment: 7 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |